Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KF2022#3-tutkimus: Teen Ja Kolajuoman Vaikutus Risperidoni-oraaliliuoksen Imeytymiseen

NCT06218979 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT06218979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06218979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KF2022#3-tutkimus: Teen Ja Kolajuoman Vaikutus Risperidoni-oraaliliuoksen Imeytymiseen
Lead sponsor
Helsinki University Central Hospital
Phase
Phase 1
Overall status
Completed
Start date
December 8, 2023
Completion date
March 14, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

food-drug interaction, psychosis